These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 21415362)

  • 21. A Prospective Evaluation of Endogenous Sex Hormone Levels and Colorectal Cancer Risk in Postmenopausal Women.
    Murphy N; Strickler HD; Stanczyk FZ; Xue X; Wassertheil-Smoller S; Rohan TE; Ho GY; Anderson GL; Potter JD; Gunter MJ
    J Natl Cancer Inst; 2015 Oct; 107(10):. PubMed ID: 26232761
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An Empirical Dietary Inflammatory Pattern Score Is Associated with Circulating Inflammatory Biomarkers in a Multi-Ethnic Population of Postmenopausal Women in the United States.
    Tabung FK; Giovannucci EL; Giulianini F; Liang L; Chandler PD; Balasubramanian R; Manson JE; Cespedes Feliciano EM; Hayden KM; Van Horn L; Rexrode KM
    J Nutr; 2018 May; 148(5):771-780. PubMed ID: 29897561
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adiposity and Endometrial Cancer Risk in Postmenopausal Women: A Sequential Causal Mediation Analysis.
    Dashti SG; English DR; Simpson JA; Karahalios A; Moreno-Betancur M; Biessy C; Rinaldi S; Ferrari P; Tjønneland A; Halkjær J; Dahm CC; Vistisen HT; Menegaux F; Perduca V; Severi G; Aleksandrova K; Schulze MB; Masala G; Sieri S; Tumino R; Macciotta A; Panico S; Hiensch AE; May AM; Quirós JR; Agudo A; Sánchez MJ; Amiano P; Colorado-Yohar S; Ardanaz E; Allen NE; Weiderpass E; Fortner RT; Christakoudi S; Tsilidis KK; Riboli E; Kaaks R; Gunter MJ; Viallon V; Dossus L
    Cancer Epidemiol Biomarkers Prev; 2021 Jan; 30(1):104-113. PubMed ID: 33008875
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inflammatory plasma markers and pancreatic cancer risk: a prospective study of five U.S. cohorts.
    Bao Y; Giovannucci EL; Kraft P; Qian ZR; Wu C; Ogino S; Gaziano JM; Stampfer MJ; Ma J; Buring JE; Sesso HD; Lee IM; Rifai N; Pollak MN; Jiao L; Lessin L; Cochrane BB; Manson JE; Fuchs CS; Wolpin BM
    Cancer Epidemiol Biomarkers Prev; 2013 May; 22(5):855-61. PubMed ID: 23462920
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Estrogen Metabolism and Risk of Postmenopausal Endometrial and Ovarian Cancer: the B ∼ FIT Cohort.
    Dallal CM; Lacey JV; Pfeiffer RM; Bauer DC; Falk RT; Buist DS; Cauley JA; Hue TF; LaCroix AZ; Tice JA; Veenstra TD; Xu X; Brinton LA;
    Horm Cancer; 2016 Feb; 7(1):49-64. PubMed ID: 26728471
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Menopause-related differences in inflammation markers and their relationship to body fat distribution and insulin-stimulated glucose disposal.
    Sites CK; Toth MJ; Cushman M; L'Hommedieu GD; Tchernof A; Tracy RP; Poehlman ET
    Fertil Steril; 2002 Jan; 77(1):128-35. PubMed ID: 11779602
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The lack of utility of circulating biomarkers of inflammation and endothelial dysfunction for type 2 diabetes risk prediction among postmenopausal women: the Women's Health Initiative Observational Study.
    Chao C; Song Y; Cook N; Tseng CH; Manson JE; Eaton C; Margolis KL; Rodriguez B; Phillips LS; Tinker LF; Liu S
    Arch Intern Med; 2010 Sep; 170(17):1557-65. PubMed ID: 20876407
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical significance of inflammatory markers in polycystic ovary syndrome: their relationship to insulin resistance and body mass index.
    Samy N; Hashim M; Sayed M; Said M
    Dis Markers; 2009; 26(4):163-70. PubMed ID: 19729797
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Circulating levels of sex steroid hormones and risk of endometrial cancer in postmenopausal women.
    Lukanova A; Lundin E; Micheli A; Arslan A; Ferrari P; Rinaldi S; Krogh V; Lenner P; Shore RE; Biessy C; Muti P; Riboli E; Koenig KL; Levitz M; Stattin P; Berrino F; Hallmans G; Kaaks R; Toniolo P; Zeleniuch-Jacquotte A
    Int J Cancer; 2004 Jan; 108(3):425-32. PubMed ID: 14648710
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Circulating levels of inflammatory markers and mammographic density among postmenopausal women.
    Reeves KW; Weissfeld JL; Modugno F; Diergaarde B
    Breast Cancer Res Treat; 2011 Jun; 127(2):555-63. PubMed ID: 21069450
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Circulating adipokine levels and endometrial cancer risk in the prostate, lung, colorectal, and ovarian cancer screening trial.
    Luhn P; Dallal CM; Weiss JM; Black A; Huang WY; Lacey JV; Hayes RB; Stanczyk FZ; Wentzensen N; Brinton LA
    Cancer Epidemiol Biomarkers Prev; 2013 Jul; 22(7):1304-12. PubMed ID: 23696194
    [TBL] [Abstract][Full Text] [Related]  

  • 32. C-reactive protein concentration and risk of selected obesity-related cancers in the Women's Health Initiative.
    Brasky TM; Kabat GC; Ho GYF; Thomson CA; Nicholson WK; Barrington WE; Bittoni MA; Wassertheil-Smoller S; Rohan TE
    Cancer Causes Control; 2018 Sep; 29(9):855-862. PubMed ID: 30046933
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Circulating soluble cytokine receptors and colorectal cancer risk.
    Ho GY; Wang T; Zheng SL; Tinker L; Xu J; Rohan TE; Wassertheil-Smoller S; Xue X; Augenlicht LH; Peters U; Phipps AI; Strickler HD; Gunter MJ; Cushman M
    Cancer Epidemiol Biomarkers Prev; 2014 Jan; 23(1):179-88. PubMed ID: 24192010
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inflammatory markers and risk of developing type 2 diabetes in women.
    Hu FB; Meigs JB; Li TY; Rifai N; Manson JE
    Diabetes; 2004 Mar; 53(3):693-700. PubMed ID: 14988254
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Circulating inflammatory and endothelial markers and risk of hypertension in white and black postmenopausal women.
    Wang L; Manson JE; Gaziano JM; Liu S; Cochrane B; Cook NR; Ridker PM; Rifai N; Sesso HD
    Clin Chem; 2011 May; 57(5):729-36. PubMed ID: 21398601
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A prospective study of inflammatory cytokines and diabetes mellitus in a multiethnic cohort of postmenopausal women.
    Liu S; Tinker L; Song Y; Rifai N; Bonds DE; Cook NR; Heiss G; Howard BV; Hotamisligil GS; Hu FB; Kuller LH; Manson JE
    Arch Intern Med; 2007 Aug 13-27; 167(15):1676-85. PubMed ID: 17698692
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum leptin-adiponectin ratio and endometrial cancer risk in postmenopausal female subjects.
    Ashizawa N; Yahata T; Quan J; Adachi S; Yoshihara K; Tanaka K
    Gynecol Oncol; 2010 Oct; 119(1):65-9. PubMed ID: 20674961
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Insulin, insulin-like growth factor-I, endogenous estradiol, and risk of colorectal cancer in postmenopausal women.
    Gunter MJ; Hoover DR; Yu H; Wassertheil-Smoller S; Rohan TE; Manson JE; Howard BV; Wylie-Rosett J; Anderson GL; Ho GY; Kaplan RC; Li J; Xue X; Harris TG; Burk RD; Strickler HD
    Cancer Res; 2008 Jan; 68(1):329-37. PubMed ID: 18172327
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hyperresistinemia is associated with postmenopausal breast cancer.
    Dalamaga M; Karmaniolas K; Papadavid E; Pelekanos N; Sotiropoulos G; Lekka A
    Menopause; 2013 Aug; 20(8):845-51. PubMed ID: 23481121
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association between dietary fiber and markers of systemic inflammation in the Women's Health Initiative Observational Study.
    Ma Y; Hébert JR; Li W; Bertone-Johnson ER; Olendzki B; Pagoto SL; Tinker L; Rosal MC; Ockene IS; Ockene JK; Griffith JA; Liu S
    Nutrition; 2008 Oct; 24(10):941-9. PubMed ID: 18562168
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.